Basel Medical Group Ltd Ordinary Shares
BMGL | NASDAQ
$5.06
+$0.02 (+0.40%)
Nov 2, 2026, 12:46 PM ET · Market open
Company Profile
Basel Medical Group Ltd, an entity established in Singapore in 2023, is dedicated to delivering a comprehensive range of healthcare services. Its operations span multiple key areas, including specialist medical expertise, medical supplies and equipment, advanced medical technology solutions, and pharmaceutical products.
Key Executives
| Name | Position |
|---|---|
| Yen Feng Chhoa | Chief Executive Officer |
| Chun How Neo | Group Chief Financial Officer |
| Boon Chye Tan | Chief Commercial Officer |
| Keng Leong Fung | Executive Chairman of the Board |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 01, 2026 | 3 | Filing |
| Sep 29, 2026 | EFFECT | Filing |
| Sep 23, 2026 | F-1/A | [Amend] Filing |
| Sep 17, 2026 | F-1 | Filing |
| Sep 02, 2026 | 6-K | Filing |
| Aug 10, 2026 | 6-K | Filing |
| Jul 31, 2026 | DRS | Filing |
| Jul 22, 2026 | 3 | Filing |
| Jul 10, 2026 | 6-K | Filing |
| Jun 26, 2026 | 6-K | Filing |
Basel Medical Group Ltd Ordinary Shares
| Country | Singapore |
| IPO Date | Feb 25, 2025 |
| Industry | Medical - Care Facilities |
| Sector | Healthcare |
| Employees | 82 |
| CEO | Yen Feng Chhoa |
Contact Details
Gleneagles Medical Centre Singapore,
CE 258499 Singapore
Stock Details
| Ticker Symbol | BMGL |
| Exchange | NASDAQ |
| Fiscal Year | July - June |
| Reporting Currency | USD |
| CIK Code | 0002004489 |
| CUSIP Number | G0864B111 |
| ISIN Number | VGG0864B1114 |
| SIC Code | 8011 |
Add to Watchlist
Select watchlists to add or remove BMGL